☆ 4.2 Article

PharmGKB summary: very important pharmacogene information for G6PD

PHARMACOGENETICS AND GENOMICS (2012)

Get Full Text
Add to Collection

Journal

PHARMACOGENETICS AND GENOMICS
Volume 22, Issue 3, Pages 219-228

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/FPC.0b013e32834eb313

Keywords

drug-induced oxidative stress; glucose-6-phosphate dehydrogenase deficiency; hemolytic anemia; pharmacodynamics; pharmacokinetics; polymorphic variants

Categories

Biotechnology & Applied Microbiology Genetics & Heredity Pharmacology & Pharmacy

Funding

  1. National Institutes of Health/National Institutes of General Medical Sciences [R24 GM61374]
  2. Spanish Ministry of Science and Innovation [Ministerio de Ciencia e Innovacion] [BIO2010-17039]
  3. Santander-Universidad Complutense de Madrid Consolidated Research Groups [920267]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.